权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The Global Hub in Medical Technologies and NanoHealth at Swansea University

斯旺西大学医疗技术和纳米健康全球中心

基本信息

批准号：
EP/K004549/1
负责人：
Steve Wilks
金额：
$ 62.83万
依托单位：
Swansea University
依托单位国家：
英国
项目类别：
Research Grant
财政年份：
2012
资助国家：
英国
起止时间：
2012 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=EP%2FK004549%2F1
关键词：
Global Hub Medical Technologies NanoHealth

项目摘要

With its Centre for NanoHealth, Swansea University leads Europe in NanoHealth and Medical Technologies, underpinned by existing and emergent international collaborations. Swansea University's Centre for NanoHealth (CNH) is a £30M investment, state of the art facility conducting research and development in medical technology and nanotechnology for healthcare. The scope and breadth of the facility is unique in Europe allowing the design, fabrication, characterization, scale up in a cleanroom, embedded in a Category 2 biological environment; CNH covers translation through a clinical research unit. CNH opened in 2009 and has been the catalyst for interdisciplinary projects spanning Engineering, Medicine, Science and hospitals, internationally and nationally. Much international collaboration has been forged through CNH's activity, particularly with leading international institutions in Medical Technologies and NanoHealth. The majority of CNH projects have direct clinical support through the University Hospital, which is co-located on campus and shares facilities. The current portfolio of externally funded projects supports over 25 RA/PDRFs and 40 PhD researchers with the involvement of circa 40 academics and clinicians, all having access to over £20M of state of the art equipment. Successful inward (interdisciplinary) and outward-reaching collaboration by CNH has attracted in excess of £16M from EPSRC, EU, MRC, TSB, the Royal Society, and industrial partners, who have a strong foothold in CNH as partners or spin-out companies. This Global Hub will go beyond the limitations of standard operational practice: time constraints, single ad hoc staff exchanges, access to facilities and budget availability tend to stifle outputs and frustrate academic vitality and pace. The Hub will lead to increased productivity from existing international links with the US and rapidly build on the early stage collaboration with France and China. The objective is to create a high-profile Global Hub centered at Swansea University. The Global Hub's programme of collaborative activity in Medical Technologies and NanoHealth focuses on four primary research clusters to intensify capacity and capability: Technology Development, Safety Assessment, Therapeutics, and Human Factors Engineering.

凭借其纳米健康中心，斯旺西大学在纳米健康和医疗技术方面领先欧洲，并以现有和新兴的国际合作为基础。斯旺西大学的纳米健康中心（CNH）是一个3000万英镑的投资，最先进的设施进行研究和开发医疗技术和纳米技术的医疗保健。该设施的范围和广度在欧洲是独一无二的，允许在洁净室中设计、制造、表征、放大，嵌入2类生物环境中; CNH通过临床研究单位提供翻译服务。CNH于2009年开业，一直是国际和国内跨学科项目的催化剂，涵盖工程，医学，科学和医院。通过CNH的活动，已经建立了许多国际合作，特别是与医疗技术和纳米健康领域的领先国际机构。大多数CNH项目都通过大学医院提供直接的临床支持，该医院位于校园内并共享设施。目前的外部资助项目组合支持超过25个RA/PDRF和40个博士研究人员，约40名学者和临床医生参与其中，所有人都可以使用超过2000万英镑的最先进设备。CNH成功的对内（跨学科）和对外合作已经吸引了来自EPSRC、EU、MRC、TSB、皇家协会和工业合作伙伴的超过1600万英镑的资金，这些合作伙伴作为合作伙伴或分拆公司在CNH拥有强大的立足点。这一全球中心将超越标准业务做法的限制：时间限制、单一的特设工作人员交流、设施的使用和预算的可得性往往会抑制产出，阻碍学术活力和步伐。该中心将提高与美国现有国际联系的生产力，并迅速建立与法国和中国的早期合作。我们的目标是创建一个以斯旺西大学为中心的备受瞩目的全球中心。全球中心在医疗技术和纳米健康方面的合作活动计划侧重于四个主要研究集群，以加强能力和能力：技术开发，安全评估，治疗学和人为因素工程。